We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
(-8.6%)
Cap. Flow
-$5.83B
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$3.97B |
| 2 |
Chevron
CVX
|
+$527M |
| 3 |
Apple
AAPL
|
+$449M |
| 4 |
Morgan Stanley
MS
|
+$426M |
| 5 |
Airbnb
ABNB
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.21B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.87B |
| 3 |
Walmart Inc
WMT
|
+$831M |
| 4 |
Amazon
AMZN
|
+$692M |
| 5 |
Eli Lilly
LLY
|
+$641M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Healthcare | 9.79% |
| 4 | Financials | 6.87% |
| 5 | Industrials | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Eton Pharmaceutcials
ETON
$1.17B
| $2.04M | ﹤0.01% |
+82,721
| New | +$1.45M |
|
1752
Daily Journal
DJCO
$792M
| $2.04M | ﹤0.01% |
+4,232
| New | +$2.31M |
|
1753
Ovid Therapeutics
OVID
$435M
| $2.04M | ﹤0.01% |
917,733
-353,754
| -28% | -$632K |
|
|
LAC
1754
Lithium Americas
LAC
$986M
| $2.03M | ﹤0.01% |
+513,847
| New | +$2.52M |
|
1755
Cellebrite
CLBT
$3.54B
| $2.02M | ﹤0.01% |
146,904
-184,726
| -56% | -$2.78M |
|
1756
WesBanco
WSBC
$3.95B
| $2.02M | ﹤0.01% |
+58,654
| New | +$2.05M |
|
1757
Bridger Aerospace
BAER
$107M
| $2.02M | ﹤0.01% |
1,021,524
+56,433
| +6% | +$137K |
|
1758
Farmers & Merchants Bancorp
FMAO
$426M
| $2.02M | ﹤0.01% |
78,779
+41,083
| +109% | +$1.07M |
|
1759
Mueller Water Products
MWA
$3.92B
| $2.02M | ﹤0.01% |
+73,431
| New | +$2.04M |
|
1760
Xometry
XMTR
$4.77B
| $2.02M | ﹤0.01% |
+49,422
| New | +$2.63M |
|
1761
American Coastal Insurance
ACIC
$498M
| $2.02M | ﹤0.01% |
179,394
+13,900
| +8% | +$156K |
|
|
EH
1762
EHang Holdings
EH
$372M
| $2.02M | ﹤0.01% |
+207,678
| New | +$2.56M |
|
1763
Nordic American Tanker
NAT
$1.37B
| $2.01M | ﹤0.01% |
+342,939
| New | +$1.62M |
|
1764
PUT
Vertex Pharmaceuticals
VRTX
$121B
| $2.01M | ﹤0.01% |
4,500
+4,100
| +1,025% | +$1.91M |
|
1765
uniQure
QURE
$2.68B
| $2.01M | ﹤0.01% |
122,736
+101,577
| +480% | +$2.06M |
|
1766
Epsilon Energy
EPSN
$176M
| $2.01M | ﹤0.01% |
325,535
-59,291
| -15% | -$303K |
|
1767
Danaher
DHR
$135B
| $1.99M | ﹤0.01% |
+10,500
| New | +$2.24M |
|
|
AVBC
1768
Avidia Bancorp
AVBC
$400M
| $1.99M | ﹤0.01% |
100,982
+21,985
| +28% | +$404K |
|
1769
Aligos Therapeutics
ALGS
$25.2M
| $1.98M | ﹤0.01% |
267,135
-1,529
| -0.6% | -$11.6K |
|
1770
Columbia Banking Systems
COLB
$8.81B
| $1.98M | ﹤0.01% |
72,201
+16,188
| +29% | +$468K |
|
1771
TriplePoint Venture Growth BDC
TPVG
$180M
| $1.98M | ﹤0.01% |
396,789
+5,941
| +2% | +$33.9K |
|
1772
Core Laboratories
CLB
$538M
| $1.98M | ﹤0.01% |
+117,744
| New | +$2.11M |
|
1773
Vulcan Materials
VMC
$36.3B
| $1.97M | ﹤0.01% |
+7,240
| New | +$2.13M |
|
1774
W.W. Grainger
GWW
$65.3B
| $1.97M | ﹤0.01% |
+1,804
| New | +$1.97M |
|
1775
NCS Multistage Holdings
NCSM
$124M
| $1.97M | ﹤0.01% |
+31,793
| New | +$1.5M |
|
Similar funds
Marshall Wace's Q1 2026 Portfolio in Review
As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.
- Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
- Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
- Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
- Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
- Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
- Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
- Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.